ACH vs ALNY · rev $1.24B vs P/E 76, rev $1.29B
Accendra Health Inc (ACH) versus Alnylam Pharmaceuticals Inc (ALNY) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Latest reported ACH revenue for 2026-06-30 was $1.24B. Net income was -$95.5M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. ACH currently screens at market cap $237.8M.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
ACH currently screens at market cap $237.8M. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Not investment advice. Open the ACH and ALNY stock pages for the full models.
Not investment advice.